Skip to main content

Table 1 The expression level of TET1 in different malignant diseases and subtypes

From: Advances in the DNA methylation hydroxylase TET1

Malignant Diseases Subtypes Expression Level of TET1
Leukemia AML Low
T-ALL High
Breast Cancer HER2 Unchanged
Triple Negative High
Lung Cancer Adenocarcinoma High
Squamous Cell Carcinoma High
Hepatocellular Carcinoma Low
Cholangiocarcinoma Intrahepatic Cholangiocarcinoma Low
Colon Cancer Low
Pancreatic Cancer Low
Prostate Cancer Low
Cervical Cancer High